Department of Breast Surgery, Shanxi Provincial Cancer Hospital, Shanxi Medical University, Taiyuan, Shanxi 030013, P.R. China.
Department of Rheumatism and Immunology, Second Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12085. Epub 2021 Apr 13.
Long non‑coding RNA (lncRNA) second chromosome locus associated with prostate‑1 (SChLAP1), also named LINC00913, has been reported to accelerate the carcinogenesis of prostate cancer. The aim of this study was to explore the role and mechanism of SChLAP1 in triple negative breast cancer (TNBC). The expression of SChLAP1 in TNBC tissues and cells was determined by reverse transcription quantitative PCR. The effects of SChLAP1 on the growth of TNBC cells was evaluated by detecting cell viability, colony formation and apoptosis. The present study determined that SChLAP1 was upregulated in TNBC tissues and was associated with the long‑distant lymph node metastasis of patients with TNBC. Knockdown of SChLAP1 significantly inhibited cell viability and colony formation, and triggered apoptosis of TNBC cells. Bioinformatics analysis suggested that SChLAP1 acted as a sponge of microRNA (miR)‑524‑5p and negatively modulated the expression of miR‑524‑5p. An inverse correlation was also identified between the expression levels of SChLAP1 and miR‑524‑5p in TNBC tissues. Furthermore, the results demonstrated that SChLAP1 interacted with miR‑524‑5p, and subsequently regulated the expression level of High Mobility Group AT‑Hook 2 (HMGA2) in TNBC cells. It was also found that the overexpression of HMGA2 rescued the suppressed viability of TNBC cells induced by SChLAP1 knockdown. In conclusion, the present findings demonstrated that SChLAP1 modulated the malignant tumor behaviors of TNBC cells by regulating HMGA2 and subsequently restraining miR‑524‑5p.
长链非编码 RNA(lncRNA)第二染色体位置与前列腺-1(SChLAP1)相关,也称为 LINC00913,已被报道可加速前列腺癌的癌变。本研究旨在探讨 SChLAP1 在三阴性乳腺癌(TNBC)中的作用和机制。通过逆转录定量 PCR 测定 TNBC 组织和细胞中 SChLAP1 的表达。通过检测细胞活力、集落形成和细胞凋亡来评估 SChLAP1 对 TNBC 细胞生长的影响。本研究确定 SChLAP1 在 TNBC 组织中上调,并与 TNBC 患者的远处淋巴结转移有关。SChLAP1 的敲低显著抑制了 TNBC 细胞的活力和集落形成,并触发了 TNBC 细胞的凋亡。生物信息学分析表明,SChLAP1 作为 microRNA(miR)-524-5p 的海绵,并负调控 miR-524-5p 的表达。还发现 SChLAP1 在 TNBC 组织中的表达水平与 miR-524-5p 呈负相关。此外,研究结果表明 SChLAP1 与 miR-524-5p 相互作用,进而调节 TNBC 细胞中高迁移率族 AT 钩 2(HMGA2)的表达水平。还发现,HMGA2 的过表达挽救了 SChLAP1 敲低诱导的 TNBC 细胞活力的抑制。总之,本研究结果表明,SChLAP1 通过调节 HMGA2 并抑制 miR-524-5p 来调节 TNBC 细胞的恶性肿瘤行为。
Aging (Albany NY). 2021-8-10
Biochem Biophys Res Commun. 2020-4-16
Biomed Pharmacother. 2017-11-24
J Cancer Res Clin Oncol. 2024-5-16
Stem Cells Int. 2022-1-22
Int J Environ Res Public Health. 2020-3-20
Biomed Pharmacother. 2020-2-10
Crit Rev Oncol Hematol. 2019-12-20
Int J Biol Macromol. 2019-12-26
Eur Rev Med Pharmacol Sci. 2019-9
Recent Pat Anticancer Drug Discov. 2019
Nucleic Acids Res. 2020-1-8